Merck Brazil

Merck Brazil is owned by Merck KGaA.

Merck KGaA is one of the...

• Dax 40;
• Forbes Global 2000 (#262).

Merck KGaA is a company listed under the stock ticker MRK (DE).

Merck KGaA has a direct presence in 17 countries.

Merck KGaA has 21 subsidiaries including Asceneuron, EMD Serono and Intermolecular.

They are in:

• Pharmaceuticals82%
• Biotechnology9%
• Other9%

View the org chart displaying its 2 main executives

Most searched biographies at Merck Brazil

• Arnaud Coelho, Managing Director and General Manager, Healthcare
• Livia Guadaim, Communications Manager

Create your alert
to follow the executive moves at Merck Brazil.

Merck KGaA has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Merck Brazil

Social media about Merck Brazil

• Merck Brazil on Wikipedia, Google News & Yahoo Finance
• Merck Brazil on LinkedIn, Twitter & YouTube

Contact by email its executives including Livia Guadaim

Call Merck Brazil at +55 119 ...

View the org chart

Register to receive your alert

Report an error